Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Aastrom Acquires Sanofi's Cell Therapy and Regenerative Medicine Business

Jun 3, 2014

Aastrom acquires Sanofi's CTRM business unit for $6.5 million.

Teva Announces New Organizational Structure and Acquisition of Labrys Biologics

Jun 3, 2014

Teva assigns new executive positions and acquires Labrys Biologics.

PharmaCell to Finalize Purchase of Cell Therapy Production Facility

Jun 3, 2014

PharmaCell has finalized its purchase of the cell therapy production facility from TiGenix.

Capsugel and Bend Research Increase Spray-Dried Dispersion Capacity

Jun 2, 2014

Bend Research installs its first commercial-scale spray dryer at its Oregon facility.

Q&A with Paul Nelles, Vetter Development Service

Paul Nelles of Vetter Development Service discusses prefilled syringes.
Jun 2, 2014

Paul Nelles of Vetter Development Service discusses prefilled syringes.

Centrifuges Increase Capacity and Flexibility

Jun 2, 2014

Centrifuges Increase Capacity and Flexibility

Single-Use Mixing System Improves Performance

Jun 2, 2014

Single-Use Mixing System Improves Performance

Hybrid Purifer Enhances Efficiency

Jun 2, 2014

Hybrid Purifer Enhances Efficiency

Bioreactor for Mammalian Cell Culture

Jun 2, 2014

Bioreactor for Mammalian Cell Culture

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
42%
No government involvement in patient treatment or drug development.
12%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here